Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease.
Katayama K, Ishii K, Terashima H, Tsuda E, Suzuki M, Yotsumoto K, Hiramoto K, Yasumatsu I, Torihata M, Ishiyama T, Muto T, Katagiri T.
Katayama K, et al. Among authors: hiramoto k.
ACS Med Chem Lett. 2020 Dec 28;12(1):121-128. doi: 10.1021/acsmedchemlett.0c00572. eCollection 2021 Jan 14.
ACS Med Chem Lett. 2020.
PMID: 33488973
Free PMC article.